Comparing the Efficacy and Safety of Adalimumab and Vedolizumab in Treating Moderate to Severe Crohn's Disease and Ulcerative Colitis Article (Faculty180)

cited authors

  • Merza, N; Nawras, Y; Saab, O; Dahiya, D S; Ahmed, Z; Ranabothu, M; Boujemaa, S; Hassan, M; Kobeissy, A; Lilley, K

authors

published in